Amazon.com, Inc. (AMZN) Traders Wager on Downside

Amazon.com, Inc. (AMZN) may venture into brick-and-mortar retail

by

Published on Feb 3, 2015 at 1:34 PM
Updated on Apr 20, 2015 at 5:32 PM

Amazon.com, Inc. (NASDAQ:AMZN) is down 0.3% this afternoon at $363.33, and options traders are gambling on additional downside through the end of the week. Specifically, buy-to-open activity is detected at the Internet marketplace's weekly 2/6 360-strike put. In other words, these speculators expect the shares to breach $360 by this Friday's close, when the weekly series expires.

By contrast, in recent sessions, option buyers have shown a decisive preference for calls over puts. AMZN's 10-day call/put volume ratio across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) stands at 1.28 -- higher than 78% of comparable readings from the last year.

This optimism is reflected among the brokerage bunch, as well. Of the 28 analysts following AMZN, 16 have doled out "buy" or better recommendations, versus 12 "holds" and not a single "sell."

Much of this positive energy is the result of AMZN's recent earnings beat. In fact, after the company posted a better-than-expected fourth-quarter profit late last week, the shares rose 13.7% in the ensuing session.

Elsewhere, Amazon.com, Inc. (NASDAQ:AMZN) is making headlines today as RadioShack Corporation (NYSE:RSH) spirals toward bankruptcy. Specifically, the former is reportedly in talks to buy some of the latter's retail locations to showcase AMZN products, and to serve as pickup and drop-off hubs.


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earning announcements before it's too late!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Latest Investor's Guide to Precious Metals
Learn how to protect savings and maximize returns by investing in precious metals.
Patent Lawsuit Loss Sends AMRN Stock Spiraling
Amarin just lost a major U.S. patent lawsuit for its heart drug Vascepa
RH Stock Sinks Despite Earnings Beat
J.P. Morgan Securities and Cowen and Company cut their price targets
The Latest Investor's Guide to Precious Metals
Learn how to protect savings and maximize returns by investing in precious metals.